{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:26:24Z","timestamp":1776842784750,"version":"3.51.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T00:00:00Z","timestamp":1644019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T00:00:00Z","timestamp":1644019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"bill and melinda gates foundation","doi-asserted-by":"publisher","award":["bill and melinda gates foundation"],"award-info":[{"award-number":["bill and melinda gates foundation"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Monitoring and Evaluation (M&amp;E) is essential in ensuring population\u2019s access to immunization. Surveys are part of this M&amp;E approach but its timing limits the use of its results to improve the coverage of the evaluated campaign. An oral cholera vaccination campaign was organized in a health district of the Far North region of Cameroon and involved an innovative M&amp;E approach. The aim of this project was to assess the feasibility and effect of using recommendations of a community-based immunization and communication coverage survey conducted after the first round of an OCV campaign on the coverage of the second-round of the campaign.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Two community-based surveys were included in the M&amp;E plan and conducted at the end of each of the campaign rounds. Data were collected by trained and closely supervised surveyors and reported using smartphones. Key results of the first-round survey were disseminated to campaign implementing team prior to the second round. The two rounds of the pre-emptive campaign were organized by the Cameroon Ministry of Public Health and partners with a two-week interval in the Mogode Health District of the Far North region of Cameroon in May and June 2017.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 120 targeted clusters, 119 (99.1%) and 117 (97.5%) were reached for the first and second rounds respectively. Among the Mogode population eligible for vaccination, the immunization coverage based on evidence (card or finger mark) were estimated at 81.0% in the first round and increased to 88.8% in the second round (X<jats:sup>2<\/jats:sup>=69.0 and p\u2009&lt;0.00). For the second round, we estimated 80.1% and 4.3% of persons who were administered 2 doses and 1 dose of OCV with evidence respectively, and 3.8% of persons who have not been vaccinated. The distribution of campaign communication coverage per health area was shared with the campaign coordination team for better planning of the second round campaign activities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>It is feasible to plan and implement coverage survey after first round OCV campaign and use its results for the better planning of the second round. For the present study, this is associated to the improvement of OCV coverage in the second-round vaccination. If this is persistent in other contexts, it may apply to improve coverage of any health campaign that is organized in more than one round.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-022-12610-5","type":"journal-article","created":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T11:02:42Z","timestamp":1644058962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["An innovative approach in monitoring oral cholera vaccination campaign: integration of a between-round survey"],"prefix":"10.1186","volume":"22","author":[{"given":"Jer\u00f4me","family":"Ateudjieu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin Ndinakie","family":"Yakum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 Pascal","family":"Goura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Tembei Ayok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Guenou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corine Blondo","family":"Kangmo Sielinou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank Forex","family":"Kiadjieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcellin","family":"Tsafack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid Marcelle","family":"Douanla Koutio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4887-8931","authenticated-orcid":false,"given":"Ketina Hirma","family":"Tchio-Nighie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Tchokomeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul Nyibio","family":"Ntsekendio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Sack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,5]]},"reference":[{"key":"12610_CR1","doi-asserted-by":"crossref","unstructured":"Ali M, Nelson AR, Lopez AL, Sack DA. Updated Global Burden of Cholera in Endemic Countries. PLoS Negl Trop Dis [Internet]. 2015 Jun 4 [cited 2021 Jun 7];9(6). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4455997\/.","DOI":"10.1371\/journal.pntd.0003832"},{"key":"12610_CR2","doi-asserted-by":"crossref","unstructured":"Ngwa MC, Liang S, Kracalik IT, Morris L, Blackburn JK, Mbam LM, et al. Cholera in Cameroon, 2000-2012: Spatial and Temporal Analysis at the Operational (Health District) and Sub Climate Levels. PLoS Negl Trop Dis [Internet]. 2016 Nov [cited 2021 Jun 7];10(11). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5113893\/.","DOI":"10.1371\/journal.pntd.0005105"},{"key":"12610_CR3","unstructured":"World Health Organization. Global Task Force on Cholera Control. CHOLERA COUNTRY PROFILE: CAMEROON. 2012 [cited 2021 Jun 7]; Available from: https:\/\/www.who.int\/cholera\/countries\/CameroonCountryProfile2011.pdf?ua=1."},{"key":"12610_CR4","unstructured":"World Health Organization (WHO). Global Task Force on Cholera Control. Prevention and control of cholera outbreaks: WHO policy and recommendations [Internet]. WHO. [cited 2021 Jun 7]; Available from: https:\/\/www.who.int\/cholera\/prevention_control\/recommendations\/en\/index5.html."},{"key":"12610_CR5","unstructured":"Organization WH. Oral cholera vaccines in mass immunization campaigns: guidance for planning and use [Internet]. World Health Organization; 2010 [cited 2021 Jun 15]. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/44448."},{"key":"12610_CR6","unstructured":"World Health Organization. Ending Cholera\u2014A Global Roadmap to 2030 [Internet]. WHO. World Health Organization; [cited 2021 Jun 7]. Available from: http:\/\/www.who.int\/cholera\/publications\/global-roadmap\/en\/."},{"issue":"1","key":"12610_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2471\/BLT.16.175166","volume":"95","author":"A Hsiao","year":"2017","unstructured":"Hsiao A, Desai SN, Mogasale V, Excler J-L, Digilio L. Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings. Bull World Health Organ. 2017 Apr;95(4)(1):303\u201312.","journal-title":"Bull World Health Organ"},{"issue":"10","key":"12610_CR8","first-page":"837","volume":"77","author":"D Legros","year":"1999","unstructured":"Legros D, Paquet C, Perea W, Marty I, Mugisha NK, Royer H, et al. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp. Bull World Health Organ. 1999;77(10):837\u201342.","journal-title":"Bull World Health Organ"},{"key":"12610_CR9","doi-asserted-by":"crossref","unstructured":"Kar SK, Sah B, Patnaik B, Kim YH, Kerketta AS, Shin S, et al. Mass Vaccination with a New, Less Expensive Oral Cholera Vaccine Using Public Health Infrastructure in India: The Odisha Model. PLoS Negl Trop Dis [Internet]. 2014 Feb [cited 2021 Jun 7];8(2). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3916257\/.","DOI":"10.1371\/journal.pntd.0002629"},{"issue":"8","key":"12610_CR10","doi-asserted-by":"publisher","first-page":"e0219040","DOI":"10.1371\/journal.pone.0219040","volume":"14","author":"E Ferreras","year":"2019","unstructured":"Ferreras E, Matapo B, Chizema-Kawesha E, Chewe O, Mzyece H, Blake A, et al. Delayed second dose of oral cholera vaccine administered before high-risk period for cholera transmission: Cholera control strategy in Lusaka, 2016. PloS One. 2019;14(8):e0219040.","journal-title":"PloS One"},{"key":"12610_CR11","doi-asserted-by":"crossref","unstructured":"Ngwa MC, Alemu W, Okudo I, Owili C, Ugochukwu U, Clement P, et al. The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey. BMJ Glob Health [Internet]. 2020 Jun 29 [cited 2021 Jun 7];5(6). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7326259\/.","DOI":"10.1136\/bmjgh-2020-002431"},{"key":"12610_CR12","doi-asserted-by":"crossref","unstructured":"Massing La, Aboubakar S, Blake A, Page Al, Cohuet S, Ngandwe A, et al. Highly targeted cholera vaccination campaigns in urban setting are feasible: The experience in Kalemie, Democratic Republic of Congo. PLoS Negl Trop Dis [Internet]. 2018 Jul 5 [cited 2021 Jun 7];12(5). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29734337\/.","DOI":"10.1371\/journal.pntd.0006369"},{"key":"12610_CR13","unstructured":"World Health Organization (WHO). Use of the two-dose oral cholera vaccine in the context of a major natural disaster Report of a mass vaccination campaign in Aceh Province, Indonesia. 2005. 2005 [cited 2021 Jun 7]; Available from: https:\/\/www.who.int\/topics\/cholera\/publications\/final_tsunami.pdf."},{"key":"12610_CR14","unstructured":"World Health Organization (WHO). Monitoring and Evaluation of AEFI during OCV mass vaccination campaigns: Working Copy. 2014 [cited 2021 Jun 7]; Available from: https:\/\/www.who.int\/cholera\/vaccines\/ocv_aefi_protocol.pdf?ua=1."},{"key":"12610_CR15","unstructured":"UNAIDS. Basic Terminology and Frameworks for Monitoring and Evaluation. 2010 [cited 2021 Jun 7]; Available from: https:\/\/www.unaids.org\/sites\/default\/files\/sub_landing\/files\/7_1-Basic-Terminology-and-Frameworks-MEF.pdf."},{"key":"12610_CR16","doi-asserted-by":"crossref","unstructured":"Uddin MJ, Adhikary G, Ali MW, Ahmed S, Shamsuzzaman M, Odell C, et al. Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh. BMC Infect Dis [Internet]. 2016 Aug 12 [cited 2021 Jun 7];16. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4983043\/.","DOI":"10.1186\/s12879-016-1758-x"},{"key":"12610_CR17","doi-asserted-by":"crossref","unstructured":"Oh DH, Dabbagh A, Goodson JL, Strebel PM, Thapa S, Giri JN, et al. Real-Time Monitoring of Vaccination Campaign Performance Using Mobile Phones - Nepal, 2016. MMWR Morb Mortal Wkly Rep. 2016 Oct 7;65(39):1072\u20136.","DOI":"10.15585\/mmwr.mm6539a5"},{"key":"12610_CR18","doi-asserted-by":"crossref","unstructured":"Sem\u00e1 Baltazar C, Rafael F, Langa Jpm, Chicumbe S, Cavailler P, Gessner, Bd, et al. Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique. PloS One [Internet]. 2018 Mar 10 [cited 2021 Jun 7];13(10). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30281604\/.","DOI":"10.1371\/journal.pone.0198592"},{"issue":"10","key":"12610_CR19","doi-asserted-by":"publisher","first-page":"e2465","DOI":"10.1371\/journal.pntd.0002465","volume":"17","author":"FJ Luquero","year":"2013","unstructured":"Luquero FJ, Grout L, Ciglenecki I, Sakoba K, Traore B, Heile M, et al. First Outbreak Response Using an Oral Cholera Vaccine in Africa: Vaccine Coverage, Acceptability and Surveillance of Adverse Events, Guinea, 2012. PLoS Negl Trop Dis. 2013;17(10):e2465.","journal-title":"PLoS Negl Trop Dis"},{"key":"12610_CR20","unstructured":"World Health Organization (WHO). ATTITUDES KNOWLEDGE. AND PRACTICES (KAP) SURVEYS DURING CHOLERA VACCINATION CAMPAIGNS: Guidance for Oral Cholera Vaccine Stockpile Campaigns: Working Copy. 2014 Jun [cited 2021 Jun 7]; Available from: https:\/\/www.who.int\/cholera\/vaccines\/kap_protocol.pdf."},{"issue":"4","key":"12610_CR21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1590\/abd1806-4841.20143705","volume":"89","author":"J Mart\u00ednez-Mesa","year":"2014","unstructured":"Mart\u00ednez-Mesa J, Gonz\u00e1lez-Chica DA, Bastos JL, Bonamigo RR, Duquia RP. Sample size: how many participants do I need in my research? An Bras Dermatol. 2014;89(4):609\u201315.","journal-title":"An Bras Dermatol"},{"key":"12610_CR22","unstructured":"World Health Organisation. Immunization Analysis and Insights: Survey methods [Internet]. [cited 2021 Oct 5]. Available from: https:\/\/www.who.int\/teams\/control-of-neglected-tropical-diseases\/yaws\/diagnosis-and-treatment\/immunization-analysis-and-insights."},{"issue":"10","key":"12610_CR23","doi-asserted-by":"publisher","first-page":"e1289","DOI":"10.1371\/journal.pntd.0001289","volume":"5","author":"D Sur","year":"2011","unstructured":"Sur D, Kanungo S, Sah B, Manna B, Ali M, Paisley AM, et al. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis. 2011;5(10):e1289.","journal-title":"PLoS Negl Trop Dis"},{"key":"12610_CR24","doi-asserted-by":"crossref","unstructured":"Azman AS, Luquero FJ, Ciglenecki I, Grais RF, Sack DA, Lessler J. The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study. PLoS Med [Internet]. 2015 Aug [cited 2021 Jun 7];12(8). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4549326\/.","DOI":"10.1371\/journal.pmed.1001867"},{"key":"12610_CR25","unstructured":"Lopez AL, Deen J, Azman AS, Luquero FJ, Kanungo S, Dutta S, et al. Immunogenicity and Protection From a Single Dose of Internationally Available Killed Oral Cholera Vaccine: A Systematic Review and Metaanalysis [Internet]. [cited 2021 Jun 7]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5982790\/."},{"issue":"10","key":"12610_CR26","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S1473-3099(17)30359-6","volume":"17","author":"Q Bi","year":"2017","unstructured":"Bi Q, Ferreras E, Pezzoli L, Legros D, Ivers LC, Date K, et al. Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(10):1080\u20138.","journal-title":"Lancet Infect Dis"},{"key":"12610_CR27","unstructured":"World Health Organisation. Training for mid-level managers (MLM) Module 5: Monitoring the Immunization system. 2008; Available from: https:\/\/www.who.int\/immunization\/documents\/MLM_module5.pdf."},{"key":"12610_CR28","doi-asserted-by":"crossref","unstructured":"Cutts Ft, Claquin P, Mc D-H, Da R. Monitoring vaccination coverage: Defining the role of surveys. Vaccine [Internet]. 2016 Jul 29 [cited 2021 Jun 7];34(35). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27349841\/.","DOI":"10.1016\/j.vaccine.2016.06.053"},{"key":"12610_CR29","unstructured":"Nour RA. Systematic Review of Methods to Improve Attitudes Towards Childhood Vaccinations. Cureus [Internet]. [cited 2021 Jun 7];11(7). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6721905\/."},{"key":"12610_CR30","doi-asserted-by":"crossref","unstructured":"Potter A, Jardine A, Morrissey A, Lindsay MDA. Evaluation of a Health Communication Campaign to Improve Mosquito Awareness and Prevention Practices in Western Australia. Front Public Health [Internet]. 2019 [cited 2021 Jun 7];7. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6433780\/.","DOI":"10.3389\/fpubh.2019.00054"},{"issue":"1","key":"12610_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-3156.2008.02196.x","volume":"14","author":"A Wallace","year":"2009","unstructured":"Wallace A, Dietz V, Cairns KL. Integration of immunization services with other health interventions in the developing world: what works and why? Systematic literature review. Trop Med Int Health TM IH. 2009;14(1):11\u20139.","journal-title":"Trop Med Int Health TM IH"},{"key":"12610_CR32","doi-asserted-by":"crossref","unstructured":"Pezzoli L, Conteh I, Kamara W, Gacic-Dobo M, Ronveaux O, Perea WA, et al. Intervene before leaving: clustered lot quality assurance sampling to monitor vaccination coverage at health district level before the end of a yellow fever and measles vaccination campaign in Sierra Leone in 2009. BMC Public Health. 2012 Jun 7;12:415.","DOI":"10.1186\/1471-2458-12-415"},{"key":"12610_CR33","doi-asserted-by":"crossref","unstructured":"Ilboudo PG, Le Gargasson J-B. Delivery cost analysis of a reactive mass cholera vaccination campaign: a case study of ShancholTM vaccine use in Lake Chilwa, Malawi. BMC Infect Dis [Internet]. 2017 Dec 19 [cited 2021 Jun 7];17. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5735524\/.","DOI":"10.1186\/s12879-017-2885-8"},{"key":"12610_CR34","doi-asserted-by":"crossref","unstructured":"Pezzoli L. Global oral cholera vaccine use, 2013-2018. Vaccine [Internet]. 2020 Feb 29 [cited 2021 Jun 7];38 Suppl 1. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31519444\/.","DOI":"10.1016\/j.vaccine.2019.08.086"},{"issue":"9","key":"12610_CR35","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.4161\/hv.20901","volume":"8","author":"C Schaetti","year":"2012","unstructured":"Schaetti C, Ali SM, Hutubessy R, Khatib AM, Chaignat C-L, Weiss MG. Social and cultural determinants of oral cholera vaccine uptake in Zanzibar. Hum Vaccines Immunother. 2012;8(9):1223\u20139.","journal-title":"Hum Vaccines Immunother"},{"issue":"1","key":"12610_CR36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1017\/S1049023X17007166","volume":"33","author":"P Schwerdtle","year":"2018","unstructured":"Schwerdtle P, Onekon C-K, Recoche K. A Quantitative Systematic Review and Meta-Analysis of the Effectiveness of Oral Cholera Vaccine as a Reactive Measure in Cholera Outbreaks. Prehospital Disaster Med. 2018;33(1):2\u20136.","journal-title":"Prehospital Disaster Med"},{"key":"12610_CR37","doi-asserted-by":"crossref","unstructured":"Oyo-Ita A, Wiysonge CS, Oringanje C, Nwachukwu CE, Oduwole O, Meremikwu MM. Interventions for improving coverage of childhood immunisation in low- and middle-income countries. Cochrane Database Syst Rev. 2016;(7).\u00a0[cited 2021 Jun 7]\u00a0Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4981642\/.","DOI":"10.1002\/14651858.CD008145.pub3"},{"issue":"3","key":"12610_CR38","first-page":"209","volume":"44","author":"P Joe","year":"2019","unstructured":"Joe P, Majgi SM, Vadiraja N, Khan MA. Influence of Sociodemographic Factors in Measles-Rubella Campaign Compared with Routine Immunization at Mysore City. Indian J Community Med Off Publ Indian Assoc Prev Soc Med. 2019;44(3):209\u201312.","journal-title":"Indian J Community Med Off Publ Indian Assoc Prev Soc Med"},{"key":"12610_CR39","doi-asserted-by":"crossref","unstructured":"Msyamboza KP, M\u2019bang\u2019ombe M, Hausi H, Chijuwa A, Nkukumila V, Kubwalo1 HW, et al. Feasibility and acceptability of oral cholera vaccine mass vaccination campaign in response to an outbreak and floods in Malawi. Pan Afr Med J. 2016;23(203).\u00a0 [cited 2021 Jun 7] Available from: https:\/\/www.panafrican-med-journal.com\/content\/article\/23\/203\/full.","DOI":"10.11604\/pamj.2016.23.203.8346"},{"issue":"44","key":"12610_CR40","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.1016\/j.vaccine.2017.10.087","volume":"22","author":"R D\u00e9molis","year":"2018","unstructured":"D\u00e9molis R, Bot\u00e3o C, Heyerdahl LW, Gessner BD, Cavailler P, Sinai C, et al. A rapid qualitative assessment of oral cholera vaccine anticipated acceptability in a context of resistance towards cholera intervention in Nampula, Mozambique. Vaccine. 2018;22(44):6497\u2013505.","journal-title":"Vaccine"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-12610-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-022-12610-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-12610-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T11:03:08Z","timestamp":1644058988000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-022-12610-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,5]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["12610"],"URL":"https:\/\/doi.org\/10.1186\/s12889-022-12610-5","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,5]]},"assertion":[{"value":"23 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All heads of households were informed of the survey and their oral consent was obtained before interviewing household members. Written consent was obtained from all the participants. Data that could reveal the identity of participants were coded. The ethical approval was obtained from the Cameroon National Ethics Committee for Human Health Research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"238"}}